What Biden’s Presidency Will Mean for Cancer Research
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
Learn how liquid biopsy could be used to detect cancer and guide treatment as researchers work to develop more...
The AACR Annual Meeting, to be held in Washington, D.C., April 1-5, will showcase the best cancer science and...
The 2024 AACR June L. Biedler Prize for Cancer Journalism winners were honored during the AACR Annual Meeting 2024.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...
The immune system is designed to operate like a well-oiled machine. With a myriad of distinct cell types, a...
In the early 1970s, German virologist Harald zur Hausen, MD, FAACR, defied the dogma that cervical cancer was caused by the herpes simplex...
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
You’re working away on your latest project when your stomach suddenly growls. Stepping away from your desk, you head...
Attendees gathered firsthand information on all things breast cancer during the five-day San Antonio Breast Cancer Symposium, which showcased...
By Cancer Today Staff News stories about efforts to eliminate and prevent cancer often tell the story in broad...
We asked Eric Winer, MD, chief of the Division of Women's Cancers and director of the Breast Oncology Center...
Guest Post by Scott M. Lippman, MD UC San Diego Moores Cancer Center
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Each year, the American Association for Cancer Research (AACR) holds Early-career Hill Day, an event that connects AACR Associate...
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
A childhood cancer survivor becomes a childhood cancer researcher.
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
After being diagnosed with stage 4 stomach cancer, Debbie Zelman, Esq., started Debbie’s Dream Foundation: Curing Stomach Cancer (DDF)...
As we spring into a new month, it is once again time for our monthly staple of Editors’ Picks. For...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
The COVID-19 pandemic has provided a strong reminder for the scientific community about the importance of public understanding and...
The AACR is pleased to offer the Global Scholar-in-Training Awards (GSITA) to eligible early-career investigators in countries building cancer...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
In a 1735 letter to the citizens of Philadelphia about the need to tighten the city’s fire safety measures,...
T-DM1, a HER2-targeted antibody-drug conjugate, improved outcomes for patients with HER2-positive, metastatic breast cancer that had progressed despite prior...
The inaugural Cancer Disparities Progress Report, published today by the American Association for Cancer Research (AACR), highlights the urgent need...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...